NASDAQ: OABIOmniab Inc Stock Ownership - Who owns Omniab?
Insider buying vs selling
Have Omniab Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John L. Higgins | Director | 2025-11-07 | 41,038 | $1.38 | $56.63kBuy |
| John L. Higgins | Director | 2025-11-06 | 36,223 | $1.41 | $51.07kBuy |
| Matthew W. Foehr | President and CEO | 2025-08-26 | 540,540 | $1.85 | $1,000.00kBuy |
| Jennifer R. Cochran | Director | 2025-05-15 | 30,000 | $1.52 | $45.60kBuy |
| Steven Love | Director | 2025-05-14 | 25,000 | $1.46 | $36.50kBuy |
| John L. Higgins | Director | 2025-05-12 | 65,000 | $1.44 | $93.60kBuy |
| Charles S. Berkman | Chief Legal Officer | 2025-04-07 | 7,206 | $2.00 | $14.41kSell |
| Kurt A. Gustafson | Executive VP Finance and CFO | 2025-04-07 | 7,206 | $2.00 | $14.41kSell |
| Matthew W. Foehr | President and CEO | 2025-04-07 | 19,382 | $2.00 | $38.76kSell |
| Kurt A. Gustafson | Executive VP Finance and CFO | 2025-04-01 | 11,963 | $2.37 | $28.35kSell |
OABI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OABI insiders and whales buy or sell their stock.
OABI Shareholders
What type of owners hold Omniab Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Avista Capital Managing Member V LLC | 11.01% | 15,855,704 | $28.70M | Insider |
| Whitefort Capital Management LP | 9.88% | 14,223,658 | $25.74M | Institution |
| Avista Acquisition GP LLC II | 5.93% | 8,534,450 | $15.45M | Insider |
| Blackrock Inc | 4.84% | 6,964,222 | $12.61M | Institution |
| Vanguard Group Inc | 3.58% | 5,148,061 | $9.32M | Institution |
| Matthew W. Foehr | 3.02% | 4,341,987 | $7.86M | Insider |
| Cadian Capital Management LP | 2.55% | 3,675,568 | $6.65M | Institution |
| John L. Higgins | 2.03% | 2,929,148 | $5.30M | Insider |
| Woodline Partners LP | 1.98% | 2,857,142 | $5.17M | Institution |
| Dimensional Fund Advisors LP | 1.77% | 2,548,284 | $4.61M | Institution |
OABI vs Biotech Stocks
Omniab Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.